Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ... British journal of pharmacology 174 (11), 1325-1348, 2017 | 1160 | 2017 |
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways AB Kunnumakkara, D Bordoloi, C Harsha, K Banik, SC Gupta, ... Clinical science 131 (15), 1781-1799, 2017 | 341 | 2017 |
An update on pharmacological potential of boswellic acids against chronic diseases NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ... International journal of molecular sciences 20 (17), 4101, 2019 | 231 | 2019 |
Is curcumin bioavailability a problem in humans: Lessons from clinical trials AB Kunnumakkara, C Harsha, K Banik, R Vikkurthi, BL Sailo, D Bordoloi, ... Expert opinion on drug metabolism & toxicology 15 (9), 705-733, 2019 | 192 | 2019 |
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets K Banik, AM Ranaware, V Deshpande, SP Nalawade, G Padmavathi, ... Pharmacological research 144, 192-209, 2019 | 169 | 2019 |
Possible use of Punica granatum (Pomegranate) in cancer therapy AD Khwairakpam, D Bordoloi, KK Thakur, J Monisha, F Arfuso, G Sethi, ... Pharmacological research 133, 53-64, 2018 | 165 | 2018 |
Alarming burden of triple-negative breast cancer in India KK Thakur, D Bordoloi, AB Kunnumakkara Clinical breast cancer 18 (3), e393-e399, 2018 | 157 | 2018 |
FBXW7 in cancer: what has been unraveled thus far? BL Sailo, K Banik, S Girisa, D Bordoloi, L Fan, CE Halim, H Wang, ... Cancers 11 (2), 246, 2019 | 154 | 2019 |
Therapeutic potential of gambogic acid, a caged xanthone, to target cancer K Banik, C Harsha, D Bordoloi, BL Sailo, G Sethi, HC Leong, F Arfuso, ... Cancer letters 416, 75-86, 2018 | 148 | 2018 |
Tocotrienols: The promising analogues of vitamin E for cancer therapeutics BL Sailo, K Banik, G Padmavathi, M Javadi, D Bordoloi, ... Pharmacological Research 130, 259-272, 2018 | 145 | 2018 |
Butein in health and disease: A comprehensive review G Padmavathi, NK Roy, D Bordoloi, F Arfuso, S Mishra, G Sethi, ... Phytomedicine 25, 118-127, 2017 | 142 | 2017 |
The potential role of boswellic acids in cancer prevention and treatment NK Roy, A Deka, D Bordoloi, S Mishra, AP Kumar, G Sethi, ... Cancer letters 377 (1), 74-86, 2016 | 138 | 2016 |
Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases AB Kunnumakkara, K Banik, D Bordoloi, C Harsha, BL Sailo, ... Frontiers in pharmacology 9, 686, 2018 | 124 | 2018 |
Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016 | 120 | 2016 |
Cancer drug development: The missing links AB Kunnumakkara, D Bordoloi, BL Sailo, NK Roy, KK Thakur, K Banik, ... Experimental Biology and Medicine 244 (8), 663-689, 2019 | 112 | 2019 |
Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression G Padmavathi, K Banik, J Monisha, D Bordoloi, B Shabnam, F Arfuso, ... Cancer letters 432, 260-271, 2018 | 109 | 2018 |
Antiulcer properties of fruits and vegetables: A mechanism based perspective C Harsha, K Banik, D Bordoloi, AB Kunnumakkara Food and chemical toxicology 108, 104-119, 2017 | 95 | 2017 |
Potential of butein, a tetrahydroxychalcone to obliterate cancer G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ... Phytomedicine 22 (13), 1163-1171, 2015 | 91 | 2015 |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ... Cancers 10 (7), 228, 2018 | 82 | 2018 |
TIPE family of proteins and its implications in different chronic diseases D Bordoloi, K Banik, B Shabnam, G Padmavathi, J Monisha, F Arfuso, ... International journal of molecular sciences 19 (10), 2974, 2018 | 72 | 2018 |